StockFacets
About
Sign-up
Sign-in
Earnings Calendar
Prices are updated after-hours
Published
Previous years
203
This month
1
This week
1
This year
9
Yesterday
1
Publishing Date
2024 - 03 - 27
2
2024 - 02 - 27
2
2023 - 12 - 18
2
2023 - 11 - 07
2
2023 - 11 - 02
2
2023 - 10 - 02
2
2023 - 08 - 04
2
2023 - 08 - 03
2
2023 - 05 - 09
2
2023 - 05 - 03
2
2022 - 05 - 10
2
2022 - 03 - 01
2
2022 - 02 - 24
3
2021 - 11 - 02
2
2021 - 10 - 26
2
2021 - 10 - 19
2
2021 - 09 - 18
2
2021 - 08 - 31
1
2021 - 08 - 30
1
2021 - 08 - 25
1
2021 - 08 - 24
1
2021 - 08 - 23
1
2021 - 08 - 18
1
2021 - 08 - 09
2
2021 - 08 - 06
1
2021 - 08 - 05
3
2021 - 08 - 04
2
2021 - 08 - 03
2
2021 - 08 - 02
1
2021 - 07 - 28
2
2021 - 07 - 27
1
2021 - 07 - 22
1
2021 - 07 - 21
1
2021 - 07 - 06
1
2021 - 06 - 26
1
2021 - 06 - 25
2
2021 - 06 - 21
1
2021 - 06 - 07
5
2021 - 06 - 04
1
2021 - 06 - 03
1
2021 - 05 - 12
1
2021 - 05 - 07
1
2021 - 05 - 06
1
2021 - 05 - 05
1
2021 - 05 - 04
1
2021 - 04 - 30
1
2021 - 04 - 28
1
2021 - 04 - 27
1
2021 - 04 - 13
1
2021 - 04 - 12
1
2021 - 04 - 08
2
2021 - 04 - 06
1
2021 - 03 - 30
3
2021 - 03 - 23
1
2021 - 03 - 18
1
2021 - 03 - 16
2
2021 - 03 - 10
1
2021 - 03 - 04
1
2021 - 01 - 29
1
2021 - 01 - 15
1
Sector
Commercial services
1
Communications
1
Distribution services
1
Health services
3
Health technology
203
Manufacturing
1
Process industries
1
Professional, scientific, and technical services
2
Retail trade
1
Technology services
1
Tags
Agreement
25
Alliances
39
Alzheimer's
23
Alzheimer’s
23
Antibody
51
Approval
46
Biomidwest
40
Biopharma
36
Biotech-bay
24
Biotechnology
25
Cancer
139
China
47
Chinese
28
Clinical-trials-phase-iii
32
Collaboration
71
Companies
51
Conference
76
Covid
62
Covid-19
48
Designation
22
Diabetes
57
Disease
89
Drug
105
Earnings
45
Events
32
Expected
24
Fda
71
Financial
65
Financial results
42
Global
149
Growth
108
Health
30
Heart
23
Insulin
37
Iot
23
License
26
Market
305
Meeting
26
Money
34
N/a
1119
Obesity
28
People
70
Pharma
35
Pharmaceutical
24
Phase 1
24
Phase 2
34
Phase 3
47
Positive
30
Report
140
Research
148
Results
203
Risk
24
Study
74
Technology
27
Therapeutics
138
Therapy
88
Tirzepatide
24
Treatment
175
Trial
116
Update
33
Entities
Abbvie inc.
79
Agnico eagle mines limited
39
Alnylam pharmaceuticals, inc.
78
Amgen inc.
53
Apollo global management, inc
41
Arrival
178
B2gold corp
37
Baidu, inc.
39
Bank of montreal
37
Barrick gold corporation
48
Beigene, ltd.
50
Biontech se
51
Bnp paribas
73
Bristol-myers squibb company
64
Brookfield asset management inc
52
Coherus biosciences, inc.
45
Cvr partners, lp
42
Cytokinetics, incorporated
41
Dirtt environmental solutions ltd.
38
Eli lilly and company
203
Enbridge inc
37
First bank
85
Fortress biotech, inc.
60
Gilead sciences, inc.
51
Idt corporation
37
Incyte corporation
72
Ionis pharmaceuticals, inc.
42
Jd.com, inc.
40
Jinkosolar holding company limited
38
Johnson & johnson
217
Kering
76
Lexicon pharmaceuticals, inc.
40
Ligand pharmaceuticals incorporated
44
Lithium corp
59
Marathon petroleum corporation
53
Mediwound ltd.
48
Morgan stanley
205
Mplx lp
53
Netease, inc.
57
Nextera energy partners, lp
42
Nextera energy, inc.
43
Novartis ag
52
Orange
330
Paid inc
167
Pfizer, inc.
62
Progressive corporation (the)
38
Provention bio, inc.
41
Regeneron pharmaceuticals, inc.
84
Sanofi
366
Seagen inc.
38
Sempra energy
39
T2 biosystems, inc.
42
Takeda pharmaceutical company limited
58
Teekay corporation
48
Teekay tankers ltd.
47
Teva pharmaceutical industries ltd
47
X financial
93
Xencor, inc.
39
Yamana gold inc.
39
Youdao, inc.
46
Symbols
ABCL
2
ABT
2
ACIU
9
ACRS
4
AKUS
1
ALNY
6
ALPMF
1
ALPMY
1
ALXO
1
AMGN
2
ARVN
2
AVEO
1
AZN
3
AZNCF
2
BGNE
3
BNR
1
BNTX
4
BYSI
1
CHRS
1
CRBU
1
CRDF
2
DERM
2
DTIL
8
EGRX
1
ELAN
1
ENDP
1
ERAS
1
EXEL
1
FBIO
2
FNCTF
1
GLAXF
1
GSK
2
HCM
4
IMGN
3
INAB
1
INCY
35
JD
1
LGND
4
LLY
203
MNKD
2
MRTX
2
MRUS
12
NVO
6
NVS
5
NVSEF
4
PFE
4
PNT
2
PRQR
6
QTRX
2
REGN
2
RIGL
11
RNA
6
SNY
14
SNYNF
13
TAK
2
UTHR
12
VERU
12
VERV
2
VNDA
2
VTRS
3
Exchanges
Nasdaq
155
Nyse
203
Crawled Date
2024 - 03 - 27
2
2024 - 02 - 27
2
2023 - 12 - 18
2
2023 - 11 - 07
2
2023 - 11 - 02
2
2023 - 10 - 02
2
2023 - 08 - 04
2
2023 - 08 - 03
2
2023 - 05 - 09
2
2023 - 05 - 03
2
2023 - 02 - 28
2
2022 - 07 - 06
2
2022 - 06 - 29
2
2022 - 03 - 30
2
2022 - 03 - 01
2
2022 - 02 - 25
2
2022 - 02 - 24
2
2021 - 11 - 02
2
2021 - 10 - 26
2
2021 - 10 - 19
2
2021 - 09 - 18
2
2021 - 08 - 31
2
2021 - 08 - 23
1
2021 - 08 - 18
1
2021 - 08 - 09
2
2021 - 08 - 06
1
2021 - 08 - 05
3
2021 - 08 - 04
2
2021 - 08 - 03
2
2021 - 08 - 02
1
2021 - 07 - 28
2
2021 - 07 - 27
1
2021 - 07 - 22
1
2021 - 07 - 21
1
2021 - 07 - 06
1
2021 - 06 - 27
1
2021 - 06 - 25
2
2021 - 06 - 21
1
2021 - 06 - 07
5
2021 - 06 - 04
1
2021 - 06 - 03
1
2021 - 05 - 12
1
2021 - 05 - 07
1
2021 - 05 - 06
1
2021 - 05 - 05
1
2021 - 05 - 04
1
2021 - 04 - 30
1
2021 - 04 - 28
1
2021 - 04 - 27
1
2021 - 04 - 13
2
2021 - 04 - 08
2
2021 - 04 - 06
1
2021 - 03 - 30
3
2021 - 03 - 23
1
2021 - 03 - 18
1
2021 - 03 - 16
2
2021 - 03 - 10
1
2021 - 03 - 04
1
2021 - 01 - 29
1
2021 - 01 - 15
1
Crawled Time
00:00
10
00:20
3
01:00
29
03:00
2
05:00
1
06:00
1
06:20
1
07:00
1
09:00
1
10:00
2
11:00
22
12:00
32
12:07
1
12:15
3
12:20
8
12:30
4
12:40
1
13:00
12
13:15
1
13:20
2
13:30
1
14:00
8
14:15
1
15:00
6
15:20
1
16:00
3
16:20
1
17:00
5
18:00
3
18:20
2
19:00
2
20:00
8
21:00
11
22:00
12
23:00
1
23:07
1
Source
investor.aveooncology.com
1
ir.vaccinex.com
1
www.biospace.com
80
www.chi-med.com
1
www.globenewswire.com
56
www.precisionbiosciences.com
2
www.prnewswire.com
62
Sort by:
after hours % change
|
delayed % change
|
gain open
|
gain high
|
gain close
|
publishing date
(GMT-12:00) International Date Line West
(GMT-11:00) American Samoa
(GMT-11:00) Midway Island
(GMT-10:00) Hawaii
(GMT-09:00) Alaska
(GMT-08:00) Pacific Time (US & Canada)
(GMT-08:00) Tijuana
(GMT-07:00) Arizona
(GMT-07:00) Chihuahua
(GMT-07:00) Mazatlan
(GMT-07:00) Mountain Time (US & Canada)
(GMT-06:00) Central America
(GMT-06:00) Central Time (US & Canada)
(GMT-06:00) Guadalajara
(GMT-06:00) Mexico City
(GMT-06:00) Monterrey
(GMT-06:00) Saskatchewan
(GMT-05:00) Bogota
(GMT-05:00) Eastern Time (US & Canada)
(GMT-05:00) Indiana (East)
(GMT-05:00) Lima
(GMT-05:00) Quito
(GMT-04:00) Atlantic Time (Canada)
(GMT-04:00) Caracas
(GMT-04:00) Georgetown
(GMT-04:00) La Paz
(GMT-04:00) Puerto Rico
(GMT-04:00) Santiago
(GMT-03:30) Newfoundland
(GMT-03:00) Brasilia
(GMT-03:00) Buenos Aires
(GMT-03:00) Greenland
(GMT-03:00) Montevideo
(GMT-02:00) Mid-Atlantic
(GMT-01:00) Azores
(GMT-01:00) Cape Verde Is.
(GMT+00:00) Casablanca
(GMT+00:00) Dublin
(GMT+00:00) Edinburgh
(GMT+00:00) Lisbon
(GMT+00:00) London
(GMT+00:00) Monrovia
(GMT+00:00) UTC
(GMT+01:00) Amsterdam
(GMT+01:00) Belgrade
(GMT+01:00) Berlin
(GMT+01:00) Bern
(GMT+01:00) Bratislava
(GMT+01:00) Brussels
(GMT+01:00) Budapest
(GMT+01:00) Copenhagen
(GMT+01:00) Ljubljana
(GMT+01:00) Madrid
(GMT+01:00) Paris
(GMT+01:00) Prague
(GMT+01:00) Rome
(GMT+01:00) Sarajevo
(GMT+01:00) Skopje
(GMT+01:00) Stockholm
(GMT+01:00) Vienna
(GMT+01:00) Warsaw
(GMT+01:00) West Central Africa
(GMT+01:00) Zagreb
(GMT+01:00) Zurich
(GMT+02:00) Athens
(GMT+02:00) Bucharest
(GMT+02:00) Cairo
(GMT+02:00) Harare
(GMT+02:00) Helsinki
(GMT+02:00) Jerusalem
(GMT+02:00) Kaliningrad
(GMT+02:00) Kyiv
(GMT+02:00) Pretoria
(GMT+02:00) Riga
(GMT+02:00) Sofia
(GMT+02:00) Tallinn
(GMT+02:00) Vilnius
(GMT+03:00) Baghdad
(GMT+03:00) Istanbul
(GMT+03:00) Kuwait
(GMT+03:00) Minsk
(GMT+03:00) Moscow
(GMT+03:00) Nairobi
(GMT+03:00) Riyadh
(GMT+03:00) St. Petersburg
(GMT+03:30) Tehran
(GMT+04:00) Abu Dhabi
(GMT+04:00) Baku
(GMT+04:00) Muscat
(GMT+04:00) Samara
(GMT+04:00) Tbilisi
(GMT+04:00) Volgograd
(GMT+04:00) Yerevan
(GMT+04:30) Kabul
(GMT+05:00) Ekaterinburg
(GMT+05:00) Islamabad
(GMT+05:00) Karachi
(GMT+05:00) Tashkent
(GMT+05:30) Chennai
(GMT+05:30) Kolkata
(GMT+05:30) Mumbai
(GMT+05:30) New Delhi
(GMT+05:30) Sri Jayawardenepura
(GMT+05:45) Kathmandu
(GMT+06:00) Almaty
(GMT+06:00) Astana
(GMT+06:00) Dhaka
(GMT+06:00) Urumqi
(GMT+06:30) Rangoon
(GMT+07:00) Bangkok
(GMT+07:00) Hanoi
(GMT+07:00) Jakarta
(GMT+07:00) Krasnoyarsk
(GMT+07:00) Novosibirsk
(GMT+08:00) Beijing
(GMT+08:00) Chongqing
(GMT+08:00) Hong Kong
(GMT+08:00) Irkutsk
(GMT+08:00) Kuala Lumpur
(GMT+08:00) Perth
(GMT+08:00) Singapore
(GMT+08:00) Taipei
(GMT+08:00) Ulaanbaatar
(GMT+09:00) Osaka
(GMT+09:00) Sapporo
(GMT+09:00) Seoul
(GMT+09:00) Tokyo
(GMT+09:00) Yakutsk
(GMT+09:30) Adelaide
(GMT+09:30) Darwin
(GMT+10:00) Brisbane
(GMT+10:00) Canberra
(GMT+10:00) Guam
(GMT+10:00) Hobart
(GMT+10:00) Melbourne
(GMT+10:00) Port Moresby
(GMT+10:00) Sydney
(GMT+10:00) Vladivostok
(GMT+11:00) Magadan
(GMT+11:00) New Caledonia
(GMT+11:00) Solomon Is.
(GMT+11:00) Srednekolymsk
(GMT+12:00) Auckland
(GMT+12:00) Fiji
(GMT+12:00) Kamchatka
(GMT+12:00) Marshall Is.
(GMT+12:00) Wellington
(GMT+12:45) Chatham Is.
(GMT+13:00) Nuku'alofa
(GMT+13:00) Samoa
(GMT+13:00) Tokelau Is.
tags :
Results
entities :
Eli lilly and company
save search
Lilly Confirms Date and Conference Call for First-Quarter 2024 Financial Results Announcement
Published:
2024-04-16
(Crawled : 15:00)
- biospace.com/
LLY
|
$750.77
0.54%
-0.04%
3.1M
|
Health Technology
|
-0.54%
|
O:
0.09%
H:
0.0%
C:
0.0%
announcement
conference
for
financial
results
Erasca Reports Fourth Quarter 2023 and Full Year 2023 Business Updates and Financial Results
Published:
2024-03-27
(Crawled : 20:00)
- globenewswire.com
NVSEF
|
$93.6375
6.88%
82K
|
Health Technology
|
-2.13%
|
O:
-100.0%
H:
NaN%
C:
Infinity%
ERAS
|
$1.845
-4.4%
-4.61%
580K
|
|
-6.31%
|
O:
17.48%
H:
6.94%
C:
-14.88%
NVS
|
$93.08
-0.13%
0.86%
1.2M
|
Health Technology
|
-3.19%
|
O:
0.52%
H:
0.0%
C:
0.0%
LLY
|
$750.77
0.54%
-0.04%
3.1M
|
Health Technology
|
-4.04%
|
O:
0.28%
H:
1.71%
C:
-0.3%
business
year
financial
results
Precision BioSciences Reports Fourth Quarter and Fiscal Year 2023 Financial Results and Provides Business Update
Published:
2024-03-27
(Crawled : 11:00)
- biospace.com/
CRBU
|
$3.92
-2.24%
-2.3%
2M
|
Health Technology
|
-20.75%
|
O:
1.58%
H:
0.58%
C:
-0.39%
NVS
|
$93.08
-0.13%
0.86%
1.2M
|
Health Technology
|
-2.57%
|
O:
0.24%
H:
0.42%
C:
0.4%
LLY
|
$750.77
0.54%
-0.04%
3.1M
|
Health Technology
|
-3.63%
|
O:
0.49%
H:
0.84%
C:
-0.07%
TGTX
|
$13.825
-1.25%
-1.27%
3.1M
|
Health Technology
|
-9.33%
|
O:
0.71%
H:
0.39%
C:
0.13%
DTIL
|
$11.5
-10.65%
-11.91%
220K
|
Health Technology
|
0.94%
|
O:
0.39%
H:
4.22%
C:
1.41%
precision
business
year
update
financial
results
ProQR Announces Year End 2023 Operating and Financial Results
Published:
2024-03-13
(Crawled : 11:00)
- globenewswire.com
LLY
|
$750.77
0.54%
-0.04%
3.1M
|
Health Technology
|
-1.09%
|
O:
0.27%
H:
0.5%
C:
0.11%
PRQR
|
$1.92
-4.0%
-4.17%
200K
|
Health Technology
|
-2.44%
|
O:
-1.46%
H:
21.78%
C:
15.35%
year
financial
results
Merus Announces Financial Results for the Fourth Quarter and Full Year 2023 and Provides Business Update
Published:
2024-02-28
(Crawled : 21:00)
- globenewswire.com
LLY
|
$750.77
0.54%
-0.04%
3.1M
|
Health Technology
|
-1.44%
|
O:
-0.6%
H:
0.45%
C:
0.08%
MRUS
|
$41.01
1.74%
1.71%
410K
|
Health Technology
|
-17.23%
|
O:
2.3%
H:
0.58%
C:
-2.69%
INCY
|
$52.74
-0.9%
-0.91%
2.5M
|
Health Technology
|
-11.27%
|
O:
0.38%
H:
0.0%
C:
-3.07%
business
year
update
financial
results
Verve Therapeutics Provides Pipeline Progress and Reports Fourth Quarter and Full Year 2023 Financial Results
Published:
2024-02-27
(Crawled : 12:30)
- globenewswire.com
VERV
|
$6.74
-5.6%
-5.93%
1.1M
|
Professional, Scientific, and T...
|
-50.55%
|
O:
5.89%
H:
15.96%
C:
14.72%
LLY
|
$750.77
0.54%
-0.04%
3.1M
|
Health Technology
|
-3.26%
|
O:
-2.2%
H:
2.39%
C:
1.34%
VRTX
|
$393.1
-0.27%
-0.27%
880K
|
Health Technology
|
-9.07%
|
O:
0.15%
H:
0.66%
C:
-0.74%
year
pipeline
therapeutics
financial
results
Aclaris Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Provides a Corporate Update
Published:
2024-02-27
(Crawled : 12:00)
- globenewswire.com
LLY
|
$750.77
0.54%
-0.04%
3.1M
|
Health Technology
|
-3.26%
|
O:
-2.2%
H:
2.39%
C:
1.34%
ACRS
|
$1.23
0.82%
0.81%
560K
|
Health Technology
|
0.83%
|
O:
2.48%
H:
10.48%
C:
-3.23%
year
update
therapeutics
financial
results
United Therapeutics Corporation Reports Fourth Quarter and Full Year 2023 Financial Results
Published:
2024-02-21
(Crawled : 12:00)
- biospace.com/
LLY
|
$750.77
0.54%
-0.04%
3.1M
|
Health Technology
|
-1.18%
|
O:
-2.33%
H:
1.55%
C:
1.06%
UTHR
|
$235.44
1.58%
1.55%
370K
|
Health Technology
|
8.23%
|
O:
2.59%
H:
3.66%
C:
-0.24%
year
corporation
therapeutics
financial
results
Lilly Confirms Date and Conference Call for Fourth-Quarter 2023 Financial Results and 2024 Financial Guidance
Published:
2024-01-23
(Crawled : 15:00)
- prnewswire.com
LLY
|
$750.77
0.54%
-0.04%
3.1M
|
Health Technology
|
18.36%
|
O:
-0.51%
H:
0.37%
C:
0.32%
conference
financial
results
Lantheus and POINT Biopharma Announce Positive Topline Results from Pivotal SPLASH Trial in Metastatic Castration-Resistant Prostate Cancer
Published:
2023-12-18
(Crawled : 12:30)
- globenewswire.com
PNT
|
$13.68
2.63%
0.15%
0
|
|
-9.84%
|
O:
-10.09%
H:
0.0%
C:
0.0%
LLY
|
$750.77
0.54%
-0.04%
3.1M
|
Health Technology
|
31.63%
|
O:
1.61%
H:
1.14%
C:
0.57%
LNTH
|
$61.49
-0.39%
-0.39%
540K
|
Health Technology
|
-18.82%
|
O:
-19.87%
H:
5.04%
C:
-8.75%
positive
cancer
biopharma
topline
trial
results
Innovent Announces Publication of Mazdutide (IBI362) Phase 2 Full Results in Chinese Patients with Overweight or Obesity in Nature Communications
Published:
2023-12-18
(Crawled : 00:00)
- prnewswire.com
LLY
|
$750.77
0.54%
-0.04%
3.1M
|
Health Technology
|
31.63%
|
O:
1.61%
H:
1.14%
C:
0.57%
SNY
|
$46.125
0.71%
0.7%
3.7M
|
Health Technology
|
-4.14%
|
O:
1.25%
H:
0.0%
C:
0.0%
INCY
|
$52.74
-0.9%
-0.91%
2.5M
|
Health Technology
|
-14.57%
|
O:
-0.03%
H:
0.06%
C:
-2.67%
ibi362
obesity
publication
communications
chinese
results
Sermonix Pharmaceuticals Shares Results of Third Survey on ESR1 and Metastatic Breast Cancer Patient Quality of Life
Published:
2023-12-12
(Crawled : 22:00)
- biospace.com/
LLY
|
$750.77
0.54%
-0.04%
3.1M
|
Health Technology
|
24.75%
|
O:
-2.88%
H:
0.0%
C:
0.0%
LGND
|
$78.93
-1.24%
-1.25%
180K
|
Health Technology
|
27.79%
|
O:
0.21%
H:
1.18%
C:
0.43%
breast
life
cancer
pharmaceuticals
results
Sermonix Pharmaceuticals Announces Publication of ELAINE-1 and ELAINE-2 Trial Results in Annals of Oncology
Published:
2023-12-11
(Crawled : 20:00)
- biospace.com/
LLY
|
$750.77
0.54%
-0.04%
3.1M
|
Health Technology
|
26.75%
|
O:
1.61%
H:
0.0%
C:
0.0%
LGND
|
$78.93
-1.24%
-1.25%
180K
|
Health Technology
|
29.28%
|
O:
0.29%
H:
1.26%
C:
0.87%
publication
pharmaceuticals
trial
results
Innovent Announces the Phase 3 ORIENT-16 Study Results Published in JAMA Evaluating Sintilimab in Combination with Chemotherapy for the First-Line Treatment of Gastric or Gastroesophageal Junction (G/GEJ) Adenocarcinoma
Published:
2023-12-06
(Crawled : 01:00)
- prnewswire.com
SNYNF
|
$92.116
-2.18%
2.3K
|
Health Technology
|
-2.28%
|
O:
-2.77%
H:
0.49%
C:
0.49%
LLY
|
$750.77
0.54%
-0.04%
3.1M
|
Health Technology
|
28.11%
|
O:
0.99%
H:
0.0%
C:
0.0%
SNY
|
$46.125
0.71%
0.7%
3.7M
|
Health Technology
|
-1.46%
|
O:
-0.6%
H:
0.0%
C:
0.0%
INCY
|
$52.74
-0.9%
-0.91%
2.5M
|
Health Technology
|
-2.92%
|
O:
-0.2%
H:
1.7%
C:
1.3%
rient-16
treatment
results
study
Innovent Announces Publication of Mazdutide (IBI362) Phase 2 Full Results in Chinese Patients with Type 2 Diabetes in Diabetes Care
Published:
2023-11-22
(Crawled : 05:00)
- prnewswire.com
SNYNF
|
$92.116
-2.18%
2.3K
|
Health Technology
|
-0.98%
|
O:
-0.74%
H:
0.71%
C:
0.71%
LLY
|
$750.77
0.54%
-0.04%
3.1M
|
Health Technology
|
24.87%
|
O:
-0.44%
H:
0.63%
C:
-0.05%
SNY
|
$46.125
0.71%
0.7%
3.7M
|
Health Technology
|
-1.55%
|
O:
-0.34%
H:
0.0%
C:
0.0%
ibi362
publication
care
chinese
diabetes
results
phase 2
POINT Biopharma Reports Third Quarter 2023 Financial Results and Provides Business Highlights
Published:
2023-11-13
(Crawled : 12:30)
- globenewswire.com
PNT
|
$13.68
2.63%
0.15%
0
|
|
-4.98%
|
O:
-0.95%
H:
0.0%
C:
0.0%
LLY
|
$750.77
0.54%
-0.04%
3.1M
|
Health Technology
|
25.31%
|
O:
-0.26%
H:
4.11%
C:
3.09%
business
biopharma
financial
results
Avidity Biosciences Reports Third Quarter 2023 Financial Results and Recent Highlights
Published:
2023-11-08
(Crawled : 21:00)
- prnewswire.com
LLY
|
$750.77
0.54%
-0.04%
3.1M
|
Health Technology
|
20.61%
|
O:
-0.71%
H:
0.14%
C:
-3.81%
RNA
|
$23.555
-1.49%
-1.51%
720K
|
Health Technology
|
341.14%
|
O:
3.51%
H:
9.47%
C:
-2.32%
financial
results
ProQR Announces Third Quarter 2023 Operating and Financial Results
Published:
2023-11-07
(Crawled : 12:00)
- globenewswire.com
LLY
|
$750.77
0.54%
-0.04%
3.1M
|
Health Technology
|
30.33%
|
O:
4.2%
H:
0.83%
C:
0.49%
PRQR
|
$1.92
-4.0%
-4.17%
200K
|
Health Technology
|
63.93%
|
O:
-2.46%
H:
21.85%
C:
13.45%
financial
results
Verve Therapeutics Highlights Recent Company Progress and Reports Third Quarter 2023 Financial Results
Published:
2023-11-07
(Crawled : 12:00)
- globenewswire.com
VERV
|
$6.74
-5.6%
-5.93%
1.1M
|
Professional, Scientific, and T...
|
-52.34%
|
O:
6.88%
H:
25.67%
C:
16.8%
LLY
|
$750.77
0.54%
-0.04%
3.1M
|
Health Technology
|
30.33%
|
O:
4.2%
H:
0.83%
C:
0.49%
company
therapeutics
financial
results
Aclaris Therapeutics Reports Third Quarter 2023 Financial Results and Provides a Corporate Update
Published:
2023-11-06
(Crawled : 12:00)
- globenewswire.com
LLY
|
$750.77
0.54%
-0.04%
3.1M
|
Health Technology
|
28.18%
|
O:
-1.66%
H:
0.0%
C:
0.0%
ACRS
|
$1.23
0.82%
0.81%
560K
|
Health Technology
|
-77.28%
|
O:
1.12%
H:
5.06%
C:
0.92%
update
therapeutics
financial
results
← Previous
1
2
3
4
5
6
7
8
9
10
11
Next →
Gainers vs Losers
56%
44%
Top 10 Gainers
INVO
|
$1.76
131.58%
56.82%
230M
|
Health Technology
SINT
|
$0.0365
59.39%
37.26%
470M
|
Health Technology
WISA
4
|
$9.19
50.66%
33.7%
65M
|
Electronic Technology
EDBL
|
$6.73
47.91%
32.39%
13M
|
GCTK
|
$0.715
36.27%
26.62%
640K
|
Manufacturing
TCON
|
$2.33
36.26%
26.61%
2M
|
Health Technology
TIRX
|
$0.48
6.43%
24.58%
4.8M
|
KZIA
|
$0.38
30.58%
23.42%
300K
|
Health Technology
VNDA
|
$5.23
29.14%
22.56%
24M
|
Health Technology
ATNF
|
$1.91
29.05%
22.51%
310K
|
Your saved searches
Save your searches and get alerts when important news are released.